series-c-plus
Stage
1
Investors
About
Avillion is a clinical development company specializing in co-developing and financing late-stage therapeutics, primarily partnering with pharmaceutical and biotech firms to guide drug candidates through trials to regulatory approval.
Explore Avillion's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.